EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 3.0

A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal

Rojana Dhakal, Maria Noula, Zoe Roupa, Edna N Yamasaki

Breast Cancer: Targets and Therapy · 2022-08 · Volume 14 · 229-246

DOI: 10.2147/bctt.s366530 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Breast Cancer: Targets and Therapy, 2022-08. Verfasst von Rojana Dhakal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Nepalaccessibility to cancer carecancer survivorsepidemiologyincidencerisk factorstreatment

Autor:innen und Institutionen

  • Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.
  • Department of Nursing, School of Health and Allied Sciences, Pokhara University, Kaski, Gandaki Province, Nepal.

Zitieren

APA

Dhakal, R., Noula, M., Roupa, Z., & Yamasaki, E. N. (2022). A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal. Breast Cancer: Targets and Therapy, Volume 14, 229-246. https://doi.org/10.2147/bctt.s366530

Vancouver

Dhakal R, Noula M, Roupa Z, Yamasaki EN. A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal. Breast Cancer: Targets and Therapy. 2022;Volume 14:229-246. doi:10.2147/bctt.s366530

BibTeX
@article{Dhakal2022,
  author = {Dhakal, Rojana and Noula, Maria and Roupa, Zoe and Yamasaki, Edna N},
  title = {A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2022},
  volume = {Volume 14},
  pages = {229--246},
  doi = {10.2147/bctt.s366530}
}
Kostenlos starten →